Seattle-based biotech Dendreon is hoping to get U.S. approval for the first cancer drug that would train the body to fight off cancer on its own, with few side effects.

FORBES: Magazine Article

From a molecular perspective, Lucentis was designed to stay in the eye and have a short half-life (two hours), while Avastin was designed to enter the circulatory system and to stick around to fight off cancer (a half-life of 20 days).

FORBES: Blinded By Savings? Is Cost Trumping Risk On Blindness Drug?

Other research suggests pterostilbene may help fight cancer and ward off diabetes.

BBC: NEWS | Health | Blueberries 'lower cholesterol'

Upstairs in her hospital room, Morris talked with Sara and Rich about the ways in which the cancer had been weakening her, making it hard for her body to fight off infection.

NEWYORKER: Letting Go